John Stamos - Public Service Announcement

Rational Therapeutics
750 East 29th St.
Long Beach, CA 90806
Phone: (562) 989-6455
Fax: (562) 989-8160
E-mail: Client.Services 800-542-HELP (4357)

Assay Endpoint

Advantages of Ex Vivo Analysis of Programmed Cell Death (EVA-PCD?) over older proliferation-based methods

  • Programmed cell death end points are more reflective of chemotherapy effects in vivo
  • Peer-reviewed published correlations with response and survival.
  • Drug and disease specific (robust)
  • Rapid, versatile, and applicable to biologic agents as well as radiation
  • Cytolysis measured in dividing and non-dividing populations
  • Accurately distinguishes tumor from non-tumor elements
  • Serial dilutions provide cytotoxic drug dose-response curves


Additional Cell Death Assays-ATP & MTT
To view these media clips you will need Real Player which is available free of charge from Real Networks. Rational Therapeutics™ employs multiple methodologies based on cell death endpoints, including the delayed loss of membrane integrity , ATP* content & MTT**signal as components of the EVA-PCD™ service

*The ATP assay is a luminescent short term suspension culture assay which functions by measuring the metabolic activity of living cells.

** The MTT assay is a colorimetric short-term suspension culture assay which functions by measuring the metabolic activity of living cells.

The different assays are applied according to specimen quality.